PCV vaccines

WHO recommends the inclusion of PCVs in childhood immunization programmes worldwide. In many countries, the routine use of PCVs has dramatically reduced the incidence of invasive pneumococcal disease with virtual disappearance of disease due to serotypes in the vaccines used.  ^{Go to footnote 11}
Between 2000 and 2015, pneumococcal deaths in children aged <5 years declined by an estimated 51%, largely due to the widespread introduction of PCVs. With continued efforts, PCVs are projected to avert approximately 2 million deaths in children aged < 5 years from 2021 through 2030.  ^{Go to footnote 22}